Pancreatic Cancer Research

ResearcherThe University of Texas Health Science Center at HoustonActive in the last 2 years

Tien C. Ko

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9000-7270; OpenAlex author ID A5028293886. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 3

  1. Increased Gremlin1 Expression in Pancreatic Ductal Adenocarcinoma Promotes a Fibrogenic Stromal Microenvironment. Last author DOI 10.1097/mpa.0000000000002378↗
  2. The TGF-β superfamily as potential therapeutic targets in pancreatic cancer. Last author DOI 10.3389/fonc.2024.1362247↗
  3. A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival. Co-author DOI 10.1245/s10434-012-2361-z↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rachel R. Tindall · 2 shared papers, 2024 · strength 0.50
  2. Jennifer M. Bailey · 2 shared papers, 2024 · strength 0.50
  3. Mamoun Younes · 1 shared paper, 2024 · strength 0.19
  4. Erika Yanil Faraoni · 1 shared paper, 2024 · strength 0.19
  5. Lillian S. Kao · 1 shared paper, 2012 · strength 0.04
  6. Eric Jay Silberfein · 1 shared paper, 2012 · strength 0.04
  7. Curtis Jackson Wray · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.